Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
enoxaparin placebo
DRUG
3 trials
Sponsors
Bristol-Myers Squibb
, Bayer
, University of Oulu
Conditions
Intracerebral Hemorrhage
Pulmonary Embolism
Venous Thromboembolism
Venous Thrombosis
Phase 2
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Completed
NCT00097357
Bristol-Myers Squibb
Pulmonary Embolism, Venous Thrombosis
Start: 2004-10-31
End: 2005-12-31
Updated: 2010-03-02
Phase 3
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Completed
NCT00571649
Bayer
Venous Thromboembolism
Start: 2007-12-31
End: 2010-11-30
Updated: 2016-09-15
Phase 4
Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage
NCT00699465
University of Oulu
Intracerebral Hemorrhage
Start: 2008-08-31
End: 2013-12-31
Target: 320
Updated: 2010-07-02
Related Papers
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials
Circulation
2022-04-07
8 citations
Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
Journal of the American Heart Association
2021-11-10
12 citations
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients
Journal of the American Heart Association
2021-02-15
42 citations
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Journal of the American College of Cardiology
2020-06-01
61 citations
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials
Thrombosis and Haemostasis
2020-01-23
18 citations
Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study
Blood
2019-11-13
9 citations
Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial
Blood
2019-11-13
2 citations
Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies
Blood
2019-11-13
The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis
Expert Review of Hematology
2017-06-15
2 citations
Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure
Circulation
2014-06-27
67 citations
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.
2014-04-01
82 citations
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
2013-02-01
397 citations